Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 2
1995 3
1996 2
1997 6
1998 2
1999 1
2000 5
2001 4
2002 7
2003 4
2004 3
2005 6
2006 4
2007 5
2008 8
2009 2
2010 2
2011 4
2012 10
2013 7
2014 9
2015 10
2016 9
2017 11
2018 8
2019 5
2020 4
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Nishio S, Yonemori K, Usami T, Minobe S, Yunokawa M, Iwata T, Okamoto A, Aoki Y, Itamochi H, Takekuma M, Harano K, Yamamoto K, Maruko T, Ugai H, Tekin C, Colombo N, Fujiwara K, Hasegawa K, Ushijima K. Nishio S, et al. Among authors: itamochi h. Cancer Sci. 2022 Nov;113(11):3877-3887. doi: 10.1111/cas.15479. Epub 2022 Sep 15. Cancer Sci. 2022. PMID: 35792064 Free PMC article. Clinical Trial.
Fertility-sparing surgery for uterine cervical cancer.
Sato S, Itamochi H, Sugiyama T. Sato S, et al. Among authors: itamochi h. Future Oncol. 2016 Oct;12(20):2345-55. doi: 10.2217/fon-2016-0260. Epub 2016 Aug 31. Future Oncol. 2016. PMID: 27578750 Review.
Surgical management of non-invasive uterine clear cell carcinoma.
Sugiyama T, Takeuchi S, Itamochi H. Sugiyama T, et al. Among authors: itamochi h. J Gynecol Oncol. 2017 Jul;28(4):e55. doi: 10.3802/jgo.2017.28.e55. J Gynecol Oncol. 2017. PMID: 28541642 Free PMC article. No abstract available.
Bevacizumab and ovarian cancer.
Sato S, Itamochi H. Sato S, et al. Among authors: itamochi h. Curr Opin Obstet Gynecol. 2012 Feb;24(1):8-13. doi: 10.1097/GCO.0b013e32834daeed. Curr Opin Obstet Gynecol. 2012. PMID: 22123222 Review.
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Okamoto A, Glasspool RM, Mabuchi S, Matsumura N, Nomura H, Itamochi H, Takano M, Takano T, Susumu N, Aoki D, Konishi I, Covens A, Ledermann J, Mezzanzanica D, Steer C, Millan D, McNeish IA, Pfisterer J, Kang S, Gladieff L, Bryce J, Oza A. Okamoto A, et al. Among authors: itamochi h. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S20-5. doi: 10.1097/IGC.0000000000000289. Int J Gynecol Cancer. 2014. PMID: 25341576 Review.
p53 gene status and chemosensitivity in ovarian cancer.
Kigawa J, Sato S, Shimada M, Takahashi M, Itamochi H, Kanamori Y, Terakawa N. Kigawa J, et al. Among authors: itamochi h. Hum Cell. 2001 Sep;14(3):165-71. Hum Cell. 2001. PMID: 11774736 Review.
135 results